Medikaloka Hermina PT (HEAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp225.37 Billion ≈ $13.21 Million USD) by net assets (Rp7.01 Trillion ≈ $410.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medikaloka Hermina PT net asset quality index to measure how much of total assets are equity-financed.
Medikaloka Hermina PT - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Medikaloka Hermina PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medikaloka Hermina PT cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Medikaloka Hermina PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medikaloka Hermina PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Patria Investments Ltd
NASDAQ:PAX
|
0.058x |
|
Baotailong New Materials Co Ltd
SHG:601011
|
-0.012x |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
-0.042x |
|
Regal Partners Ltd
AU:RPL
|
0.048x |
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D
IS:KRDMD
|
0.031x |
|
WhiteFiber, Inc. Ordinary Shares
NASDAQ:WYFI
|
-0.035x |
|
National Grid PLC
LSE:NG
|
0.076x |
|
Hangzhou Jiebai Group Co Ltd
SHG:600814
|
0.048x |
Annual Cash Flow Conversion Efficiency for Medikaloka Hermina PT (2015–2024)
The table below shows the annual cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Medikaloka Hermina PT worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp5.87 Trillion ≈ $343.74 Million |
Rp1.14 Trillion ≈ $66.66 Million |
0.194x | -23.61% |
| 2023-12-31 | Rp5.20 Trillion ≈ $304.60 Million |
Rp1.32 Trillion ≈ $77.33 Million |
0.254x | +136.20% |
| 2022-12-31 | Rp4.69 Trillion ≈ $274.55 Million |
Rp503.58 Billion ≈ $29.51 Million |
0.107x | -74.60% |
| 2021-12-31 | Rp4.39 Trillion ≈ $257.02 Million |
Rp1.86 Trillion ≈ $108.77 Million |
0.423x | +27.07% |
| 2020-12-31 | Rp3.38 Trillion ≈ $198.18 Million |
Rp1.13 Trillion ≈ $66.01 Million |
0.333x | +60.80% |
| 2019-12-31 | Rp2.76 Trillion ≈ $161.98 Million |
Rp572.58 Billion ≈ $33.55 Million |
0.207x | +103.10% |
| 2018-12-31 | Rp2.37 Trillion ≈ $138.86 Million |
Rp241.67 Billion ≈ $14.16 Million |
0.102x | -79.03% |
| 2017-12-31 | Rp956.53 Billion ≈ $56.05 Million |
Rp465.08 Billion ≈ $27.25 Million |
0.486x | +68.84% |
| 2016-12-31 | Rp1.26 Trillion ≈ $73.83 Million |
Rp362.85 Billion ≈ $21.26 Million |
0.288x | +7.84% |
| 2015-12-31 | Rp957.59 Billion ≈ $56.11 Million |
Rp255.71 Billion ≈ $14.98 Million |
0.267x | -- |
About Medikaloka Hermina PT
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more